Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Women's Health' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Women's Health Worldwide Prescription Drug Markets |
August 2006 | £2575 | 100 % |
|
Women's Health Worldwide Prescription Drug Markets |
August 2006 | £1300 | 100 % |
|
Women's Health: Diagnostic Testing |
August 2008 | £1200 | 97 % |
|
Women's Health Clinical Trial Analysis |
July 2009 | £660 | 96 % |
|
Women's Health Market Outlook to 2011 |
May 2007 | £1495 | 96 % |
|
European Markets for Women's Health Devices (15 Countries) Executive Summary for Report |
August 2009 | £130 | 95 % |
|
European Markets for Women's Health Devices (15 Countries) |
August 2009 | £7590 | 95 % |
|
Women's Health - Endometriosis Drug Pipeline Report |
February 2008 | £655 | 95 % |
|
European Markets for Women's Health Devices (15 Countries) |
August 2009 | £7590 | 95 % |
|
Women's Health - Infertility Drug Pipeline Report |
February 2008 | £655 | 95 % |
|
European Markets for Women's Health Devices (15 Countries) Executive Summary for Report |
August 2009 | £130 | 95 % |
|
Women's Health - Contraception Drug Pipeline Report |
February 2008 | £655 | 95 % |
|
Women's Health - Vaginal Infections Drug Pipeline Report |
February 2008 | £655 | 94 % |
|
Women's Health - Menopausal Symptoms Drug Pipeline Report |
February 2008 | £655 | 94 % |
|
Women's Health: Worldwide Prescription Drug Markets, 4th Edition |
February 2009 | £1980 | 94 % |
|
Women's Health - Female Sexual Dysfunction Drug Pipeline Report |
February 2008 | £655 | 93 % |
|
U.S. Market for Women's Health Devices 2009 |
January 2009 | £4950 | 49.5 % |
|
U.S. Market for Women's Health Devices 2009 |
January 2009 | £4950 | 49.5 % |
|
New Therapeutics and Diagnostics for Women’s Disorders |
May 2005 | £2885 | 37 % |
|
Nutraceuticals |
April 2007 | £899 | 34.65 % |
|
Sciele Pharma Inc Premium Company Profile |
December 2007 | £175 | 31.5 % |
|
Offices of General and Family Practice Physicians in the US IBISWorld Industry Report |
August 2007 | £430 | 29 % |
|
Medical litigation Health campaigners talk about medical litigation in the USA and Europe |
March 2006 | £400 | 28.7 % |
|
Mammography World Markets |
October 2008 | £2245 | 27.5 % |
|
Women's Reproductive Disorders Therapeutics 2008-2018 |
September 2008 | £1499 | 26 % |
|
Warner Chilcott Ltd Premium Company Profile |
January 2008 | £175 | 25.5 % |
|
Mayo Clinic Internal Medicine Concise Textbook |
September 2007 | £55 | 24.5 % |
|
Atlas of Endometriosis 5th edition |
September 2007 | £75 | 24 % |
|
Female Sexual Dysfunction Prescription Drug Pipeline Overview 2007 |
July 2007 | £1320 | 23.45 % |
|
CHRISTUS Health - Strategic Analysis Review |
June 2009 | £83 | 22.5 % |
|
Hologic Medical Device Company Intelligence Report |
March 2009 | £295 | 22.5 % |
|
Launching Combination Products Brand Extension and Franchise Development Strategies |
January 2008 | £1995 | 21.35 % |
|
Endometriosis Drug Pipeline Analysis and Market Forecasts to 2016 |
February 2010 | £1320 | 19.95 % |
|
PepsiCo: The World's Biggest Functional Food Company 10 Case Studies In Its Strategies In Sports Drinks, Fruit Drink, Snack Innovation And Cereals |
February 2007 | £145 | 19.25 % |
|
American Medical Systems Holdings, Inc. - Healthcare - Medical Equipment - SWOT Report |
September 2008 | £83 | 18.9 % |
|
Patients' rights: the views of health campaigners from Eastern Europe Eastern European health campaigners' latest views on patients' rights in their countries |
October 2006 | £400 | 18.55 % |
|
7-Eleven: Towards Healthy Convenience |
October 2007 | £75 | 18.5 % |
|
Cooper Companies Medical Device Company Intelligence Report |
October 2009 | £295 | 18 % |
|
Japanese Market for Women's Health Devices 2009 |
October 2009 | £4950 | 17.85 % |
|
Australia Pharmaceuticals & Healthcare |
February 2009 | £250 | 17.5 % |
|
Partners HealthCare System, Inc. - Strategic Analysis Review |
March 2009 | £83 | 17 % |
|
Pharmacological and Psychosocial Treatments in Schizophrenia |
January 2008 | £35.95 | 16.45 % |
|
Johnson & Johnson Medical Device Company Intelligence Report |
August 2009 | £695 | 16 % |
|
Wound Care, 3rd. Edition, Vol. III: Surgical and Trauma Wounds |
September 2007 | £1980 | 15.5 % |
|
Ethicon Medical Device Company Intelligence Report |
August 2009 | £195 | 15.5 % |
|
Global Markets for Breast Biopsy Devices 2009 |
September 2009 | £7590 | 15.4 % |
|
Health and Wellness Beverages in Ireland |
November 2006 | £650 | 15.4 % |
|
Specialty Pharma Market Outlook, The Key players, new company growth models and emerging opportunities |
October 2006 | £1495 | 15.05 % |
|
Wyeth - Financial and Strategic Analysis Review |
April 2009 | £83 | 15 % |
|
Managing Clinical Investigator Compensation |
May 2009 | £5080 | 14.7 % |
|
Barr Pharmaceuticals - SWOT Analysis |
October 2008 | £44 | 14.5 % |
|
Reformulation Strategies Comparisons of Past and Future Reformulation Strategies |
September 2006 | £2640 | 14.5 % |
|
Seeking Beauty Through Nutrition |
August 2006 | £975 | 14.35 % |
|
Medical Ultrasound Systems Market Worldwide. 2009 |
July 2009 | £1650 | 14.35 % |
|
Intermountain Healthcare, Inc. - Strategic Analysis Review |
March 2009 | £83 | 14 % |
|
Success and Failure in Functional Water Eleven Case Studies From Europe, The U.S. And Asia |
November 2006 | £160 | 14 % |
|
Schering-Plough Pipeline ,Products ,Performance ,Potential |
August 2008 | £595 | 14 % |
|
Global Markets for Assisted Reproductive Devices 2009 |
September 2009 | £7590 | 13.65 % |
|
Health Benefit Platforms & Strategies in Breakfast Cereals 17 Key Case Studies |
January 2007 | £145 | 13.65 % |
|
Martek Biosciences Corp: Premium Company Profile Premium Company Profile |
January 2008 | £175 | 13.5 % |
|
Premium Company Profile Antares Pharma |
November 2007 | £175 | 13.5 % |
|
Pharmaceutical Regulatory Industry |
January 2006 | £2885 | 13.3 % |
|
Quintiles Transnational Corp. - Strategic Analysis Review |
July 2009 | £83 | 13 % |
|
Sciele Pharma, Inc. - SWOT Analysis |
December 2008 | £44 | 13 % |
|
Solvay Prospects to 2010 Pipeline, Products,Performance,Potential |
December 2008 | £595 | 12.6 % |
|
Pharma R&D Fact Book, The 2006 |
November 2007 | £495 | 12.6 % |
|
Chinese Markets for Cancer Treatment Drugs |
September 2005 | £2640 | 12.6 % |
|
Women First Healthcare Inc. -Financial Company Report |
February 2008 | £115 | 12.5 % |
|
Wyeth Prospects to 2010 Performance, Products, Pipeline and Potential |
July 2007 | £595 | 12 % |
|
Stakeholder Insight: Osteoporosis Generic alendronate further establishes oral bisphosphonates as gold standard |
October 2008 | £5285 | 11.9 % |
|
UCB Schwarz: PharmaVitae Profile |
February 2007 | £1980 | 11.55 % |
|
The World Market for Gynaecology 2007-2017 |
September 2007 | £3200 | 11.5 % |
|
Stakeholder Opinions: Female Sexual Dysfunction Results from Datamonitor's 2005 physician survey |
June 2007 | £1325 | 11.2 % |
|
Bionovo, Inc. - Financial and Strategic Analysis Review |
June 2009 | £83 | 11.2 % |
|
Key Opinion Leaders: Relationship Management and Segmentation Data |
February 2009 | £5080 | 11 % |
|
Eye Care in Thailand |
July 2008 | £450 | 10.85 % |
|
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market |
April 2008 | £5285 | 10.85 % |
|
Health and Wellness Healthcare Products in India |
November 2006 | £650 | 10.85 % |
|
Major World Markets for Stents and The Economics of Drug-Eluting Technology |
May 2008 | £1850 | 10.85 % |
|
Mammography Equipment Clinical Trial Analysis |
July 2009 | £660 | 10.85 % |
|
Health and Wellness Healthcare Products in Ireland |
December 2006 | £650 | 10.5 % |
|
NRT Smoking Cessation Aids in Thailand |
July 2008 | £450 | 10.5 % |
|
Analgesics in Thailand |
July 2008 | £450 | 10.5 % |
|
Digestive Remedies in Thailand |
July 2008 | £450 | 10.5 % |
|
Shire: Pipeline • Products • Performance • Potential |
December 2008 | £595 | 10.5 % |
|
Vitamins and Dietary Supplements in Thailand |
July 2008 | £450 | 10.15 % |
|
Medicated Skin Care in Thailand |
July 2008 | £450 | 10.15 % |
|
Computed Tomography (CT) Systems Market Worldwide 2009 |
April 2009 | £1650 | 10 % |
|
Innovations in Cancer Novel Therapeutics, New Diagnostics and Future R&D Strategies |
February 2007 | £1495 | 10 % |
|
Health and Wellness Healthcare Products in Mexico |
January 2007 | £650 | 9.8 % |
|
Maximizing Your Brand Value |
August 2007 | £4620 | 9.8 % |
|
Health and Wellness Healthcare Products in Russia |
December 2006 | £650 | 9.8 % |
|
Innovation in Drug Delivery The future of nanotechnology and non-invasive protein delivery |
November 2006 | £1495 | 9.5 % |
|
Pierre Fabre: PharmaVitae Profile |
November 2006 | £3000 | 9.45 % |
|
The Medical Device Market: Belgium |
January 2010 | £595 | 9.45 % |
|
Next-Generation Nutraceuticals Food and pharma convergence in disease prevention and personalized nutrition |
December 2006 | £1495 | 9.45 % |
|
Pipeline and Commercial Insight: Osteoporosis Novel agents to battle for payer acceptance |
July 2009 | £10040 | 9.1 % |
|
Gastrointestinal Endoscopy Equipment: The Global Market |
August 2009 | £3205 | 9.1 % |
|
How Drugs Are Developed 3rd Edition |
January 2007 | £1095 | 9 % |
|
How To Attract New Sports Nutrition Consumers Using Mainstream Health Trends To Pitch Professional-Style Products |
August 2006 | £975 | 8.75 % |
|
Eu Paediatric Medicines Regulation Boon or Burden? |
January 2007 | £1095 | 8.5 % |
|
Prebiotics |
February 2010 | £2280 | 8.4 % |
|
Hologic, Inc. Healthcare - Medical Equipment SWOT Report |
August 2008 | £83 | 8.4 % |
|
Nutraceuticals and Dietary Supplements Markets |
September 2007 | £2245 | 8.4 % |
|
GSK's Cervarix A Future Blockbuster of 2007 |
March 2007 | £1999 | 8.4 % |
|
Dietary supplements market in Poland 2009 Development forecasts 2009-2011 |
March 2009 | £1345 | 8.4 % |
|
Digestive Remedies in Chile |
July 2008 | £450 | 8.05 % |
|
Diabetes Drug Discoveries 2009: what the future holds |
February 2009 | £795 | 8.05 % |
|
Wound Treatments in Switzerland |
April 2009 | £560 | 8.05 % |
|
Qiagen N.V. Product Pipeline Analysis |
August 2008 | £495 | 8.05 % |
|
Bone Densitometers Global Trends |
November 2009 | £1980 | 8.05 % |
|
Global Healthcare IT Investment Opportunities Analysis and Forecasts to 2015 |
May 2009 | £2640 | 8.05 % |
|
Analgesics in Chile |
July 2008 | £450 | 8.05 % |
|
Analgesics in Switzerland |
April 2009 | £560 | 8.05 % |
|
Eye Care in Chile |
July 2008 | £450 | 8.05 % |
|
Eye Care in Switzerland |
April 2009 | £560 | 8.05 % |
|
GE Healthcare Medical Device Company Intelligence Report |
April 2009 | £495 | 8.05 % |
|
Digestive Remedies in Switzerland |
April 2009 | £560 | 8.05 % |
|
Wound Treatments in Chile |
July 2008 | £450 | 8.05 % |
|
Health and Wellness Healthcare Products in Spain |
February 2007 | £650 | 8.05 % |
|
Stakeholder Opinions: Hormonal Contraceptives New directions in a competitive market |
November 2006 | £1325 | 7.7 % |
|
Blood Pressure Monitoring & Measurement Instruments A World Market Analysis |
November 2009 | £1980 | 7.7 % |
|
Health and Wellness Healthcare Products in Norway |
December 2006 | £650 | 7.7 % |
|
Medicated Skin Care in Chile |
July 2008 | £450 | 7.7 % |
|
NRT Smoking Cessation Aids in Switzerland |
April 2009 | £560 | 7.7 % |
|
Medicated Skin Care in Switzerland |
April 2009 | £560 | 7.7 % |
|
Vitamins And Dietary Supplements in Switzerland |
April 2009 | £560 | 7.7 % |
|
Hiv/Aids Testing World Review |
November 2009 | £1980 | 7.7 % |
|
The Market for Minimally Invasive Medical Devices |
March 2009 | £3205 | 7.35 % |
|
Cough, Cold And Allergy (Hay Fever) Remedies in Switzerland |
April 2009 | £560 | 7.35 % |
|
Disease Management and Drug Adherence Strategies to support patients and enhance treatment persistence |
July 2007 | £2510 | 7 % |
|
Future Product Opportunities in Cosmeceuticals Innovation in food and drinks with beauty benefits |
July 2007 | £995 | 7 % |
|
Chemotherapy Market Insights, 2006-2016 A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities |
April 2006 | £1900 | 7 % |
|
Winning Pharmaceutical Brand Management Maximizing brand value through best practice in brand development and product marketing |
March 2006 | £1495 | 7 % |
|
Hologic, Inc. Product Pipeline Analysis |
August 2008 | £495 | 7 % |
|
Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008, The |
June 2008 | £1499 | 7 % |
|
Condoms A World Market Review |
November 2009 | £1980 | 6.65 % |
|
Pipeline Insight Therapeutic Cancer Vaccines A turbulent path from bench to bedside |
October 2007 | £1980 | 6.65 % |
|
Electronic Handheld Blood Pressure Devices A Worldwide Market Review |
November 2009 | £1980 | 6.65 % |
|
Medical Imaging Markets, Volume I Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and Ct Markets) |
February 2009 | £2310 | 6.65 % |
|
ScientiaVision Product Pinpoint: The New Vaccines |
March 2009 | £1980 | 6.65 % |
|
Stakeholder Opinion: Erectile Dysfunction Identifying product differentiation and patient segmentation strategies |
December 2006 | £1325 | 6.65 % |
|
Strategies and Solutions for Publication Planning and Execution Excellence |
September 2007 | £75 | 6.65 % |
|
United States Healthcare IT Investment Opportunities Analysis and Forecasts to 2015 |
March 2009 | £1650 | 6.65 % |
|
Ultrasound Systems Clinical Trial Analysis |
July 2009 | £660 | 6.65 % |
|
Breast Biopsy Devices |
February 2010 | £2280 | 6.65 % |
|
Multiplex Assays in Translational Medicine Technologies, Applications, and Future Directions |
February 2008 | £745 | 6.65 % |
|
Commercial Insight: Osteoporosis Risk management and reformulation offer best defense against generic onslaught |
June 2007 | £5020 | 6.3 % |
|
Pipeline Insight: Anxiety Disorders A decade of declining revenues |
March 2006 | £4290 | 6.3 % |
|
Virology Clinical Trial Analysis |
July 2009 | £660 | 6.3 % |
|
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family Sales & Marketing |
October 2007 | £2510 | 6.3 % |
|
Sleep Disorders Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking |
March 2009 | £1320 | 6.3 % |
|
Transdermal Drug Delivery Technologies, Markets and Companies |
March 2010 | £1850 | 5.95 % |
|
Physician Office Laboratory (POL) Testing Markets Worldwide Status Quo and Future Trends |
May 2007 | £2310 | 5.95 % |
|
Merck & Co: PharmaVitae Profile |
November 2006 | £1980 | 5.95 % |
|
Biogen Idec: PharmaVitae Profile PharmaVitae Profile |
March 2007 | £1980 | 5.95 % |
|
Probiotics A Global Update of Market Trends & Opportunities |
November 2009 | £1980 | 5.95 % |
|
Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) |
November 2008 | £1650 | 5.6 % |
|
Pfizer Prospects to 2010 Pipeline, Products,Performance,Potential |
September 2007 | £595 | 5.6 % |
|
Pipeline Insight: Antiarrhythmics RSD1235 in a class of its own |
May 2006 | £4290 | 5.25 % |
|
Medical Nonwoven Disposables A Worldwide Market Review |
November 2009 | £1980 | 5.25 % |
|
Stakeholder Opinions: Bladder Cancer New drugs needed to challenge ineffective 20 year old drugs |
November 2008 | £1320 | 5.25 % |
|
Pipeline Insight: Cancer Overview Increasing Diversity Offers Both High Risk And Reward |
September 2007 | £5020 | 5.25 % |
|
Autoimmune Disease Therapeutics |
July 2009 | £2610 | 5.25 % |
|
Ear Protection Devices |
February 2010 | £2610 | 5.25 % |
|
Pipeline Insight: Molecular Targeted Cancer Therapies Can anything else revolutionize the market? - Cancer |
October 2007 | £5020 | 4.9 % |
|
Lateral Flow Technology and the Future of Point of Care Diagnostics |
February 2007 | £1980 | 4.9 % |
|
Improve Market Research Impact |
December 2008 | £5080 | 4.9 % |
|
Patient Monitoring Markets |
October 2009 | £2245 | 4.9 % |
|
Medical Imaging Devices A Global Market Overview |
September 2009 | £2970 | 4.9 % |
|
Computed Tomography Systems Clinical Trial Analysis |
July 2009 | £660 | 4.55 % |
|
Medical Imaging Markets |
June 2009 | £2245 | 4.55 % |
|
U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products |
March 2006 | £1980 | 4.55 % |
|
The Cardiovascular Disorders Market Outlook to 2012 |
February 2008 | £1995 | 4.55 % |
|
Bariatric (Obesity) Surgical Devices |
July 2009 | £1620 | 4.2 % |
|
Generic League Market Analysis and Forecasts, 2007-2012, 2017 & 2022 |
February 2008 | £1999 | 4.2 % |
|
Infectious Immunology Test Reagents Clinical Trial Analysis |
July 2009 | £660 | 4.2 % |
|
Pediatric Health Care Products and Services |
March 2009 | £3205 | 4.2 % |
|
Commercial Insight: Antidyslipidemics Branded statins beware, generics are amongst you |
July 2006 | £5575 | 3.85 % |
|
Cold, Cough, And Sore Throat Remedies |
February 2010 | £2610 | 3.85 % |
|
Monoclonal Antibodies Report Part I |
June 2007 | £2510 | 3.85 % |
|
What's Hot in Cancer Drug R&D? |
July 2006 | £295 | 3.85 % |
|
Point of Care Diagnostics: Players, Products & Future Market Prospects |
November 2009 | £995 | 3.5 % |
|
Neurodegenerative Disease Drug Market Analysis and Forecasts 2007 |
June 2007 | £1999 | 3.5 % |
|
Commercial Insight: Antihypertensives New challenges for a maturing market |
September 2006 | £5285 | 3.5 % |
|
Terumo Medical Device Company Intelligence Report |
February 2006 | £295 | 3.15 % |
|
High-Growth Diagnostic Testing Markets |
November 2008 | £2245 | 3.15 % |
|
Personalized Medicine Scientific & Commercial Aspects |
March 2010 | £2640 | 3.15 % |
|
Anti-Infectives |
February 2010 | £2610 | 2.45 % |
|
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008 |
May 2007 | £280 | 2.1 % |
|
PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2009 / 2010 |
June 2009 | £280 | 2.1 % |
|
Cardiovascular Catherers and Systems |
January 2007 | £2545 | 1.75 % |
